» Articles » PMID: 38907632

All Women with Multiple Sclerosis Should Start Hormone Replacement Therapy at Menopause Unless Contraindicated: Yes

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2024 Jun 22
PMID 38907632
Authors
Affiliations
Soon will be listed here.
References
1.
Itoh N, Itoh Y, Meyer C, Suen T, Cortez-Delgado D, Lomeli M . Estrogen receptor beta in astrocytes modulates cognitive function in mid-age female mice. Nat Commun. 2023; 14(1):6044. PMC: 10533869. DOI: 10.1038/s41467-023-41723-7. View

2.
MacKenzie-Graham A, Brook J, Kurth F, Itoh Y, Meyer C, Montag M . Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry. Brain Behav. 2018; 8(9):e01086. PMC: 6160650. DOI: 10.1002/brb3.1086. View

3.
Voskuhl R, Wang H, Wu T, Sicotte N, Nakamura K, Kurth F . Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2015; 15(1):35-46. DOI: 10.1016/S1474-4422(15)00322-1. View

4.
Kim R, Mangu D, Hoffman A, Kavosh R, Jung E, Itoh N . Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis. Brain. 2017; 141(1):132-147. PMC: 5837360. DOI: 10.1093/brain/awx315. View

5.
Voskuhl R, Itoh Y . The X factor in neurodegeneration. J Exp Med. 2022; 219(12). PMC: 9641640. DOI: 10.1084/jem.20211488. View